Friday, 13 Sep 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
13 Apr 2016 Social Majority of PSS patients will have ILD (fibrotic NSIP). ILD is the leading cause of death in PSS (courtesy Aryeh Fischer, Natl Jewish Hosp)
13 Jun 2016 Social NEJM vignette showing Gastrointestinal complications of GPA; bowel vasculitis, hemorrhage, hemoperitoneum https://t.co/I13vFVPeAL
10 Nov 2015 Social Check out video of Dr Peter Merkel on ANCA-Assoc Vaculitis from RheumNow. #ACR15. https://t.co/4pn5XAm4RV
25 Nov 2015 Social RT @DrPetryna: @RheumNow Vitamin D levels may predict cognitive impairment in patients with #SLE https://t.co/oDI3GtUMvj
07 Feb 2017 Social Belimumab RCTs shows promising renal effects. 55% improved renal outcomes, 71% improved proteinura, renal flare=1.7% https://t.co/4VLHmJmIhb
29 Apr 2017 Social RT @DrRachelTate: Granulomas: macs, T cells and dendritic cells necessary for formation. Dr. Weyand @RheumNow #SOTA2017 https://t.co/7w3DXU…
05 Nov 2017 Social RT @_connectedcare: Anti NXP-2 antibodies identify 85% of those with cancer associated dermatomyositis #ACR17 @rheumnow https://t.co/6BXnFC…
10 Nov 2017 Social RT @isa75012: PulmHTN and ILD now leading cause of death in #scleroderma #GR https://t.co/6q2i9yWdB8
25 Oct 2018 Social RT @CCalabreseDO: checkpoint inhibitor-related myositis has unique phenotype - myocarditis, myasthenia gravis-like symptoms abstract #2976…
18 Mar 2019 Social European Commission Approves MabThera (rituximab) for use in Pemphigus, US FDA approved it in 6/18; RTX is now approved in 4 autoimmune disorders in the US & Europe (RA, GPA, MPA, Pemphigus) - Not approved for use in children https://t.co/dJJfPdXuWQ(rituxim/364143/index.html
30 Jul 2019 Social Cohort study shows ACE inhib. in Systemic Sclerosis at Dx was assoc w/ increased risk for Scleroderma Renal Crisis (SRC). Military System EHR study of 31 SRC to 332 non-SRC & found ACEi assoc w/ SRC (OR 4.1; CI 1.6–10.2) only in presence of proteinuria https://t.co/cMsheXrmRY
29 Apr 2015 Social Alliance for Lupus Research and Janssen w/ do a study of Ustekinumab in SLE later this year http://buff.ly/1HHo9l4 
16 Nov 2016 Social RT @rachelthuston: Key US findings in GCA per #OMERACT #ACR16 @RheumNow https://t.co/Dm1Sr0qOkf https://t.co/9jjzZnozfZ
30 Apr 2017 Social RT @DrRachelTate: Sicca management options. Pearls: fluoride treatments + monitoring for thrush (Beware: sugar in otc meds!) A. Baer, MD @R…
06 Nov 2017 Social RT @DrRachelTate: Novel Anti-CD40 monoclonal ab CFZ533 potential benefit in Sjogren's Syndrome. #ACR17 @RheumNow #1784 https://t.co/sehIStK…
12 Apr 2018 Social Study of 150 SLE pts shows that fracture risk is increased with age, body mass index, fat mass, smoking, and rheumatoid arthritis. https://t.co/9b3ewmrVtc
20 Jul 2018 Social Lancet article - Baricitinib 4 mg (not 2mg) shown to be effective in SLE. After 24 weeks SLEDAI-2K responses were Bari 4 mg 67% vs 53% PB0. https://t.co/KWqMJcDHF2
16 Apr 2019 Social Immunomonitoring with microarrays from the SLE PROMISE pregnancy study shows that adverse outcomes (preeclampsia) can be identified by quantifying plasma cell, interferon and neutrophil RNA levels during the pregnancy https://t.co/81cBGA3hKx.
17 Sep 2015 Social DrPetryna A study reveals Female patients with #Polymyositis may suffer from subclinical ovarian dysfunction. http://t.co/EA747xrvp1
26 Jul 2016 Social CHMP has recommended abatacept for 1st line use (before MTX) in moderate to severe RA. EMA to consider approval https://t.co/kXyD1cXKbO